Royal Bank of Canada Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $43.00

Acadia Healthcare (NASDAQ:ACHC) had its price target decreased by Royal Bank of Canada from $64.00 to $43.00 in a research note issued to investors on Monday,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock.

Other analysts have also recently issued research reports about the stock. Bank of America cut their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. TD Cowen lowered their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Finally, Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $56.31.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $29.68 on Monday. The firm has a 50-day moving average of $41.79 and a 200-day moving average of $51.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a market cap of $2.76 billion, a PE ratio of 9.73, a P/E/G ratio of 1.46 and a beta of 1.30. Acadia Healthcare has a 52-week low of $28.09 and a 52-week high of $85.96.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds have recently bought and sold shares of the company. Lindbrook Capital LLC grew its holdings in shares of Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after purchasing an additional 345 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC grew its holdings in shares of Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp grew its holdings in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after purchasing an additional 454 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.